Headache and biomarkers predictive of vascular disease in a representative sample of US children

Archives of Pediatrics and Adolescent Medicine

Volumn 164, Issue 4, 2010, Pages 358-362

  Nelson, Karin B ^a,b   Richardson, Amanda Kalaydjian ^c   He, Jianping ^c   Lateef, Tarranum M ^b,c   Khoromi, Suzan ^c   Merikangas, Kathleen R ^c  

^a NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

^b CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

^c NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; CYANOCOBALAMIN; FOLIC ACID; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HOMOCYSTEINE; METHYLMALONIC ACID; TRIACYLGLYCEROL; URIC ACID;

ADOLESCENT; ADULT; ARTICLE; BODY MASS; CARDIOVASCULAR RISK; CEREBROVASCULAR DISEASE; CHILD; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; ERYTHROCYTE; HEADACHE; HEALTH SURVEY; HUMAN; INFORMATION PROCESSING; MAJOR CLINICAL STUDY; MEDICAL INFORMATION; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; THROMBOCYTE COUNT; UNITED STATES; BLOOD; CARDIOVASCULAR DISEASE; CLUSTER ANALYSIS; CROSS-SECTIONAL STUDY; HEADACHE AND FACIAL PAIN; INFLAMMATION; MIGRAINE; RECURRENT DISEASE; RISK FACTOR; SEX RATIO; STATISTICAL MODEL;

ADOLESCENT; BIOLOGICAL MARKERS; CARDIOVASCULAR DISEASES; CEREBROVASCULAR DISORDERS; CHILD; CHILD, PRESCHOOL; CLUSTER ANALYSIS; CROSS-SECTIONAL STUDIES; HEADACHE DISORDERS; HUMANS; INFLAMMATION; LOGISTIC MODELS; MIGRAINE DISORDERS; RECURRENCE; RISK FACTORS; SEX DISTRIBUTION; UNITED STATES; YOUNG ADULT;

EID: 77950942999     PISSN: 10724710     EISSN: 15383628     Source Type: Journal    
DOI: 10.1001/archpediatrics.2010.17     Document Type: Article

References (42)

1. Wilson PW, Bozeman SR, Burton TM, Hoaglin DC, Ben-Joseph R, Pashos CL. Prediction of first events of coronary heart disease and stroke with consideration of adiposity. Circulation. 2008;118(2):124-130.
2. Sanossian N, Tarlov NE. HDL-C and LDL-C: their role in stroke pathogenesis and implications for treatment. Curr Treat Options Cardiovasc Med. 2008;10(3):195-206.
3. Abi-Saleh B, Iskandar SB, Elgharib N, Cohen MV. C-reactive protein: the harbinger of cardiovascular diseases. South Med J. 2008;101(5):525-533. (Pubitemid 351643398)
4. Makita S, Nakamura M, Satoh K, et al. Serum C-reactive protein levels can be used to predict future ischemic stroke and mortality in Japanese men from the general population. Atherosclerosis. 2009;204(1):234-238.
5. Zee RY, Mora S, Cheng S, et al. Homocysteine, 5,10- methylenetetrahydrofolate reductase 677C>T polymorphism, nutrient intake, and incident cardiovascular disease in 24,968 initially healthy women. Clin Chem. 2007;53(5):845-851. (Pubitemid 46744239)
6. Towfighi A, Saver JL, Engelhardt R, Ovbiagele B. Factors associated with the steep increase in late-midlife stroke occurrence among US men. J Stroke Cerebrovasc Dis. 2008;17(4):165-168. (Pubitemid 351858611)
7. Monastero R, Pipia C, Cefalu AB, et al. Association between plasma lipid levels and migraine in subjects aged > or =50 years: preliminary data from the Zabut Aging Project. Neurol Sci. 2008;29(suppl 1):S179-S181. (Pubitemid 351836996)
8. Keith SW, Wang C, Fontaine KR, Cowan CD, Allison DB. BMI and headache among women: results from 11 epidemiologic datasets. Obesity (Silver Spring). 2008;16(2):377-383. (Pubitemid 351271919)
9. Vanmolkot FH, de Hoon JN. Increased C-reactive protein in young adult patients with migraine. Cephalalgia. 2007;27(7):843-846.
10. Moschiano F, D'Amico D, Usai S, et al. Homocysteine plasma levels in patients with migraine with aura. Neurol Sci. 2008;29(suppl 1):S173-S175. (Pubitemid 351836994)
11. Scher AI, Gudmundsson LS, Sigurdsson S, et al. Migraine headache in middle age and late-life brain infarcts. JAMA. 2009;301(24):2563-2570.
12. Bigal ME, Kurth T, Hu H, Santanello N, Lipton RB. Migraine and cardiovascular disease: possible mechanisms of interaction. Neurology. 2009;72(21):1864-1871.
13. Rook JL, Nugent DJ, Young G. Pediatric stroke and methylenetetrahydrofolate reductase polymorphisms: an examination of C677T and A1298C mutations. J Pediatr Hematol Oncol. 2005;27(11):590-593. (Pubitemid 41697344)
14. Glueck CJ, Bates SR. Migraine in children: association with primary and familial dyslipoproteinemias. Pediatrics. 1986;77(3):316-321.
15. Bottini F, Celle ME, Calevo MG, et al. Metabolic and genetic risk factors for migraine in children. Cephalalgia. 2006;26(6):731-737. (Pubitemid 43909245)
16. Lateef TM, Merikangas KR, He J, et al. Headache in a national sample of American children: prevalence and comorbidity. J Child Neurol. 2009;24(5):536-543.
17. Wannamethee SG, Shaper AG, Whincup PH, Walker M. Role of risk factors for major coronary heart disease events with increasing length of follow up. Heart. 1999;81(4):374-379. (Pubitemid 29167126)
18. Merikangas K, He J, Brody D, Fisher PW, Bourdon K, Koretz D. Prevalence and correlates of mental disorders and services in US children: results from NHANES 2001-2004 [published online December 14, 2009]. Pediatrics. doi:10.1542/peds.2008-2598.
19. Brna P, Dooley J, Gordon K, Dewan T. The prognosis of childhood headache: a 20-year follow-up. Arch Pediatr Adolesc Med. 2005;159(12):1157-1160. (Pubitemid 41758636)
20. Virtanen R, Aromaa M, Rautava P, et al. Changing headache from preschool age to puberty: a controlled study. Cephalalgia. 2007;27(4):294-303. (Pubitemid 46434954)
21. Lewis DW. Pediatric migraine. Neurol Clin. 2009;27(2):481-501.
22. Wöber-Bingöl C, Wöber C, Wagner-Ennsgraber C, et al. IHS criteria for migraine and tension-type headache in children and adolescents. Headache. 1996;36(4):231-238. (Pubitemid 26150827)
23. Gallai V, Sarchielli P, Carboni F, Benedetti P, Mastropaolo C, Puca F; Juvenile Headache Collaborative Study Group. Applicability of the 1988 IHS criteria to headache patients under the age of 18 years attending 21 Italian headache clinics. Headache. 1995;35(3):146-153.
24. Maytal J, Young M, Shechter A, Lipton RB. Pediatric migraine and the International Headache Society (IHS) criteria. Neurology. 1997;48(3):602-607. (Pubitemid 27120092)
25. Gherpelli JL, Nagae Poetscher LM, Souza AM, et al. Migraine in childhood and adolescence: a critical study of the diagnostic criteria and of the influence of age on clinical findings. Cephalalgia. 1998;18(6):333-341.
26. Hämäläinen ML, Hoppu K, Santavuori PR. Effect of age on the fulfilment of the IHS criteria for migraine in children at a headache clinic. Cephalalgia. 1995;15(5):404-409.
27. Battistella PA, Fiumana E, Binelli M, et al. Primary headaches in preschool children: clinical study and follow-up in 163 patients. Cephalalgia. 2006;26(2):162-171.
28. Kalaydjian A, Merikangas K. Physical and mental comorbidity of headache in a nationally representative sample of US adults. Psychosom Med. 2008;70(7):773-780.
29. Kampoli AM, Tousoulis D, Antoniades C, Siasos G, Stefanadis C. Biomarkers of premature atherosclerosis. Trends Mol Med. 2009;15(7):323-332.
30. Lambert M, Delvin EE, Paradis G, O'Loughlin J, Hanley JA, Levy E. C-reactive protein and features of the metabolic syndrome in a population-based sample of children and adolescents. Clin Chem. 2004;50(10):1762-1768. (Pubitemid 39298005)
31. Cook DG, Mendall MA, Whincup PH, et al. C-reactive protein concentration in children: relationship to adiposity and other cardiovascular risk factors. Atherosclerosis. 2000;149(1):139-150.
32. Glynn RJ, MacFadyen JG, Ridker PM. Tracking of high sensitivity C-reactive protein after an initially elevated concentration: the JUPITER Study. Clin Chem. 2009;55(2):305-312.
33. Pfeiffer CM, Johnson CL, Jain RB, et al. Trends in blood folate and vitamin B-12 concentrations in the United States, 1988-2004. Am J Clin Nutr. 2007;86(3):718-727.
34. Vargas BB. Tension-type headache and migraine: two points on a continuum? Curr Pain Headache Rep. 2008;12(6):433-436.
35. Cady RK. The convergence hypothesis. Headache. 2007;47(suppl 1):S44-S51.
36. Kapiotis S, Holzer G, Schaller G, et al. A proinflammatory state is detectable in obese children and is accompanied by functional and morphological vascular changes. Arterioscler Thromb Vasc Biol. 2006;26(11):2541-2546. (Pubitemid 44607478)
37. Järvisalo MJ, Harmoinen A, Hakanen M, et al. Elevated serum C-reactive protein levels and early arterial changes in healthy children. Arterioscler Thromb Vasc Biol. 2002;22(8):1323-1328. (Pubitemid 34875744)
38. Ridker PM, Danielson E, Fonseca FAH, et al; JUPITER Study Group. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl J Med. 2008;359(21):2195-2207.
39. Avis HJ, Vissers MN, Wijburg FA, Kastelein JJ, Hutten BA. The use of lipid-lowering drug therapy in children and adolescents. Curr Opin Investig Drugs. 2009;10(3):224-231.
40. O'Gorman CS, Higgins MF, O'Neill MB. Systematic review and meta-analysis of statins for heterozygous familial hypercholesterolemia in children: evaluation of cholesterol changes and side effects. Pediatr Cardiol. 2009;30(4):482-489.
41. Wärnberg J, Marcos A. Low-grade inflammation and the metabolic syndrome in children and adolescents. Curr Opin Lipidol. 2008;19(1):11-15.
42. Berenson GS, Srinivasan SR, Bao W, Newman WP III, Tracy RE, Wattigney WA. Association between multiple cardiovascular risk factors and atherosclerosis in children and young adults: the Bogalusa Heart Study. N Engl J Med. 1998;338(23):1650-1656. (Pubitemid 28267909)